These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9201649)

  • 1. Neuroendocrine correlates of chronic fatigue syndrome: a brief review.
    Demitrack MA
    J Psychiatr Res; 1997; 31(1):69-82. PubMed ID: 9201649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome.
    Demitrack MA; Crofford LJ
    Ann N Y Acad Sci; 1998 May; 840():684-97. PubMed ID: 9629295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome.
    Crofford LJ
    Z Rheumatol; 1998; 57 Suppl 2():67-71. PubMed ID: 10025087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
    Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs.
    Gold PW; Licinio J; Wong ML; Chrousos GP
    Ann N Y Acad Sci; 1995 Dec; 771():716-29. PubMed ID: 8597444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in response to vasopressin infusion in chronic fatigue syndrome.
    Altemus M; Dale JK; Michelson D; Demitrack MA; Gold PW; Straus SE
    Psychoneuroendocrinology; 2001 Feb; 26(2):175-88. PubMed ID: 11087963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine mechanisms in fibromyalgia-chronic fatigue.
    Buskila D; Press J
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):747-58. PubMed ID: 11812019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Van Houdenhove B; Cosyns P; Claes SJ
    Neuropsychobiology; 2007; 55(2):112-20. PubMed ID: 17596739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome.
    Griep EN; Boersma JW; de Kloet ER
    J Rheumatol; 1993 Mar; 20(3):469-74. PubMed ID: 8386766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology.
    Cho HJ; Skowera A; Cleare A; Wessely S
    Curr Opin Psychiatry; 2006 Jan; 19(1):67-73. PubMed ID: 16612182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of Long COVID.
    Yavropoulou MP; Tsokos GC; Chrousos GP; Sfikakis PP
    Clin Immunol; 2022 Dec; 245():109133. PubMed ID: 36182048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic fatigue syndrome and fibromyalgia. Dilemmas in diagnosis and clinical management.
    Demitrack MA
    Psychiatr Clin North Am; 1998 Sep; 21(3):671-92, viii. PubMed ID: 9774804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia.
    Parker AJ; Wessely S; Cleare AJ
    Psychol Med; 2001 Nov; 31(8):1331-45. PubMed ID: 11722149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome.
    Bradley LA; McKendree-Smith NL; Alarcón GS
    Curr Rev Pain; 2000; 4(2):148-57. PubMed ID: 10998728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of chronic fatigue.
    Streeten DH
    JAMA; 1998 Sep 23-30; 280(12):1094-5. PubMed ID: 9757860
    [No Abstract]   [Full Text] [Related]  

  • 18. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.
    Tanriverdi F; Karaca Z; Unluhizarci K; Kelestimur F
    Stress; 2007 Mar; 10(1):13-25. PubMed ID: 17454963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans.
    Michelson D; Galliven E; Hill L; Demitrack M; Chrousos G; Gold P
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2601-6. PubMed ID: 9253341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.